There are two basic ways to do fractions on your iPhone calculator. Here's what you need to know to use the built-in app.

Tislelizumab addition to CRT improved survival in ESCC, with group B showing a 1-year PFS rate of 73% and OS rate of 85%. The trial's primary endpoint was PFS, with secondary endpoints including OS, ...